Skip to content

Scott E Lukas

7 papers in the library · 120 citations · publishing 2002-2026

Papers

Sort Most recent Most cited

Monday mood decline after weekend ecstasy use: A retrospective analysis of daily diary reports.

Drug and Alcohol Dependence Reports June 1, 2026 Christopher Medina-Kirchner, Scott E Lukas

Ecstasy is commonly used on weekends and linked to post-use mood declines. Laboratory studies with pure MDMA rarely detect residual effects, whereas naturalistic studies more often report mood reductions. The timing and contextual drivers of these effects remain unclear. Data from seventeen participants reporting weekend ecstasy use (10 male, 7 female; 19-38 years) were drawn from a previously...

Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics.

Journal of Psychopharmacology 2026 Jack E Henningfield, Frederick S. Barrett, Suzette M Evans et al.

This review provides an overview of Roland R. Griffiths' history of research, and his mentoring and collaborating approach to science that contributed to his impact in behavioral and neuropsychopharmacology and psychedelic medicines development. The approach was to summarize studies in his major domains of research, including preclinical and clinical abuse liability assessment science, alcohol,...

DOI: 10.1177/02698811251398801 (opens in new tab) Full text (opens in new tab) Abuse liability Caffeine Psychedelics Sedatives +1

Chronic cannabis use alters dACC-striatal glutamatergic balance.

Pharmacology, Biochemistry, and Behavior April 2023 Chun S. Zuo, Scott E Lukas

Prefrontal and striatal glutamate plays an important role in modulating striatal dopamine levels and an imbalance in regional glutamate has been identified in several psychiatric conditions. We hypothesized that this imbalance also exists in cannabis use disorder (CUD). We recently quantified the difference in glutamate of dorsal anterior cingulate (dACC) and striatum regions in the...

Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs.

Frontiers in Psychiatry 2019 Jordan K Zjawiony, Antônio S Machado, Ricardo Menegatti et al. 18 citations

Over the years, pain has contributed to low life quality, poor health, and economic loss. Opioids are very effective analgesic drugs for treating mild, moderate, or severe pain. Therapeutic application of opioids has been limited by short and long-term side effects. These side effects and opioid-overuse crisis has intensified interest in the search for new molecular targets and drugs. The...

Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.

Neuropsychopharmacology December 1, 2015 Michael S. Placzek, Genevieve C Van de Bittner, Hsiao‐ying Wey et al.

Monitoring changes in opioid receptor binding with positron emission tomography (PET) could lead to a better understanding of tolerance and addiction because altered opioid receptor dynamics following agonist exposure has been linked to tolerance mechanisms. We have studied changes in kappa opioid receptor (KOR) binding availability in vivo with PET following kappa opioid agonist...

Transdermal nicotine alters some of marihuana's effects in male and female volunteers.

Drug and Alcohol Dependence August 1, 2005 David M Penetar, Elena M Kouri, Michelle M Gross et al.

Despite the fact that tobacco and marihuana are often used together, relatively little is known about the effects of this combination. In order to investigate the effects of the principal psychoactive component in tobacco smoke, nicotine, on marihuana-induced intoxication, we conducted a double blind, cross-over experiment using nicotine transdermal patches. Ten male and 10 female participants...

Long-Term Neuropsychiatric Consequences of "Ecstasy" (MDMA): A Review

Harvard Review of Psychiatry 2002 Alonso Montoya, Renée Sorrentino, Scott E Lukas et al. 102 citations

The recreational drug "ecstasy" (3,4-methylenedioxymethamphetamine, or MDMA) is widely used by young people throughout the world. Experimental studies indicate that MDMA damages serotonergic neurons in animals and possibly in humans. Repeated use may induce long-term neurotoxic effects, with cognitive and behavioral implications. We reviewed both the preclinical and the clinical literature to...